Since Dorset Business Angels was founded almost a decade ago, its USP and appeal to entrepreneurs, investors and the business community

USA: CyberCube, the market leader in cyber risk analytics, has announced $50 million in additional growth capital 

Fact360, a cyber-security SaaS platform that specialises in detecting fraud, financial crime and compliance anomalies within businesses, has received investment from one Henley Business Angels member, contributing towards a funding round of £500,000.

Two leading doctors who developed a new health coaching platform after the untimely death of a colleague have raised over £1m in a funding round led by private equity firm Traditum and backed by angel investors.  The funding will enable physiologist and serial entrepreneur Dr Michael Stein and Oxford University’s Professor Chris Butler to develop their Added Health platform further and roll it out to a wider audience.

Edinburgh-based investment syndicate, Archangels, invested £13.4m during 2022 in some of Scotland’s most promising early-stage tech and life science companies. The total investment for 2022 among 11 businesses marks a 14% increase on Archangels’ investment activity in 2021 (11.8m).  New additions to the portfolio included tech firm Earth Blox who secured £1.5m funding from Archangels to expand its global reach and further develop its no-code Earth Observation (EO) cloud-based SaaS.

James Murdoch considers a reduction in sales from his portfolio during the financial crisis.

Finance and technology heavyweight, Dominique Cerutti, has given his backing to London based early stage fintech, 1fs Wealth, and its innovative platform that can support wealth owners to consolidate and manage their assets.

CheMastery has raised a seed round led by Science Angel Syndicate, the deep science investor group, and Undeterred Capital. The round was supported by Elbow Beach Capital, Britbots, HERmesa, Fink Family Office, Kadmos Capital, Formic Ventures, Cur8, Key Ventures, Dhyan and angel investors.

Jellagen, an innovative biotech company and leader in biomaterials derived from jellyfish, has closed a successful £8.7m Series A equity investment round.

Elizabeth Humphrey, Financial Crime Researcher at Themis discusses the issues around mangaing financial risk due diligence and why it is such an imporant element of comprehensive due diligence for investors and founders alike.

USA: The Launch Place has announced its $250,000 investment in Revibe Technologies, a North Carolina-based startup developing digital therapy software for wearables to treat attention-deficit/hyperactivity disorder (ADHD) and autism. After bringing its flagship artificial intelligence-driven smartwatch and wristband to the adolescent market, the company is iterating on its success with FokusRx—a nonpharmacologic software-as-a-medical device (SaMD) approach to treating attention and focus deficits.

An innovative British start-up, Collective Equity, has launched the UK’s first equity pooling fund to give liquidity to founders who have their entire wealth tied up in the businesses they create. Founders and shareholders can invest up to 10% of their equity, instead of cash, into the fund and share in the success of other high-growth, vetted companies. When one or more of the Limited Partners in the fund has a liquidity event, such as an IPO or acquisition, everyone in the fund receives a share of the proceeds. This gives founders multiple opportunities to convert their equity into cash.